FDA warns about safety risks of tailored weight-loss drugs

The U.S. Food and Drug Administration
warned about the safety risks of using compounded or
custom-made versions of popular weight-loss drugs such as Wegovy
and diabetes drug Ozempic.
... | June 1, 2023

Related Keywords

Bengaluru ,Karnataka ,India ,Denmark ,Danish ,Novo Nordisk Wegovy ,Novo Nordisk Ozempic ,Drug Administration ,Reuters ,Novo Nordisk ,Mariam Sunny ,Rashmi Aich ,Novo Nordiskas Stock Exchange ,News ,Information ,Press Release ,The ,Wood ,End ,Drug ,Arned ,Bout ,Safety ,Risks ,F ,Sing ,Compounded ,Versions ,Popular ,Drugs ,Much ,Us ,Diabetes ,Rug Novob Dk0060534915 ,